CAS 145821-60-9
:3-Piperidinecarboxylic acid, 1-[4,4-bis(3-methyl-2-thienyl)-3-buten-1-yl]-, ethyl ester, hydrochloride (1:1), (3R)-
Description:
3-Piperidinecarboxylic acid, 1-[4,4-bis(3-methyl-2-thienyl)-3-buten-1-yl]-, ethyl ester, hydrochloride (1:1), (3R)-, is a chemical compound characterized by its complex structure, which includes a piperidine ring and a thienyl substituent. The presence of the piperidine moiety suggests potential applications in medicinal chemistry, particularly in the development of pharmaceuticals due to its ability to interact with biological targets. The ethyl ester functional group indicates that the compound may exhibit lipophilic properties, enhancing its permeability through biological membranes. The hydrochloride salt form implies increased solubility in aqueous environments, which is beneficial for drug formulation. The stereochemistry denoted by (3R) indicates a specific three-dimensional arrangement of atoms, which can significantly influence the compound's biological activity and interaction with receptors. Overall, this compound's unique structural features may contribute to its potential therapeutic effects, making it a subject of interest in drug discovery and development.
Formula:C22H29NO2S2·ClH
InChI:InChI=1S/C22H29NO2S2.ClH/c1-4-25-22(24)18-7-5-11-23(15-18)12-6-8-19(20-16(2)9-13-26-20)21-17(3)10-14-27-21;/h8-10,13-14,18H,4-7,11-12,15H2,1-3H3;1H/t18-;/m1./s1
InChI key:InChIKey=OMDTXVBMKZQQCF-GMUIIQOCSA-N
SMILES:C(=CCCN1C[C@H](C(OCC)=O)CCC1)(C2=C(C)C=CS2)C3=C(C)C=CS3.Cl
Synonyms:- 3-Piperidinecarboxylic acid, 1-[4,4-bis(3-methyl-2-thienyl)-3-buten-1-yl]-, ethyl ester, hydrochloride (1:1), (3R)-
- Ethyl tiagabinate hydrochloride
- 3-Piperidinecarboxylic acid, 1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-, ethyl ester, hydrochloride, (R)-
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 2 products.
(R)-Tiagabine 4-carboxy-o-ethyl hydrochloride
CAS:Tiagabine is an ester hydrochloride that is used to treat the symptoms of Parkinson's disease. Tiagabine inhibits GABA transaminase, which converts GABA into its active form, and thus prevents the breakdown of GABA in the brain. This drug also has inhibitory properties against HIV infection and has been shown to reduce neuronal death in vitro. Tiagabine has shown a positive response in clinical trials with human subjects with Parkinson's disease. Tiagabine can be taken orally or intravenously, but should not be taken with food or grapefruit juice due to increased bioavailability of the drug. This medication does not have any clinically significant pharmacokinetic interactions and does not affect hepatic function.Formula:C22H30ClNO2S2Purity:Min. 95%Molecular weight:440.06 g/mol
